Cargando…
Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection
Plasmacytoid dendritic cells (pDC) are the major source of type I interferons (IFN‐I) during viral infections, in response to triggering of endosomal Toll‐like receptors (TLRs) 7 or 9 by viral single‐stranded RNA or unmethylated CpG DNA, respectively. Synthetic ligands have been used to disentangle...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166132/ https://www.ncbi.nlm.nih.gov/pubmed/30131424 http://dx.doi.org/10.15252/embj.201798836 |
_version_ | 1783359978071916544 |
---|---|
author | Tomasello, Elena Naciri, Karima Chelbi, Rabie Bessou, Gilles Fries, Anissa Gressier, Elise Abbas, Abdenour Pollet, Emeline Pierre, Philippe Lawrence, Toby Vu Manh, Thien‐Phong Dalod, Marc |
author_facet | Tomasello, Elena Naciri, Karima Chelbi, Rabie Bessou, Gilles Fries, Anissa Gressier, Elise Abbas, Abdenour Pollet, Emeline Pierre, Philippe Lawrence, Toby Vu Manh, Thien‐Phong Dalod, Marc |
author_sort | Tomasello, Elena |
collection | PubMed |
description | Plasmacytoid dendritic cells (pDC) are the major source of type I interferons (IFN‐I) during viral infections, in response to triggering of endosomal Toll‐like receptors (TLRs) 7 or 9 by viral single‐stranded RNA or unmethylated CpG DNA, respectively. Synthetic ligands have been used to disentangle the underlying signaling pathways. The adaptor protein AP3 is necessary to transport molecular complexes of TLRs, synthetic CpG DNA, and MyD88 into endosomal compartments allowing interferon regulatory factor 7 (IRF7) recruitment whose phosphorylation then initiates IFN‐I production. High basal expression of IRF7 by pDC and its further enhancement by positive IFN‐I feedback signaling appear to be necessary for robust cytokine production. In contrast, we show here that in vivo during mouse cytomegalovirus (MCMV) infection pDC produce high amounts of IFN‐I downstream of the TLR9‐to‐MyD88‐to‐IRF7 signaling pathway without requiring IFN‐I positive feedback, high IRF7 expression, or AP3‐driven endosomal routing of TLRs. Hence, the current model of the molecular requirements for professional IFN‐I production by pDC, established by using synthetic TLR ligands, does not strictly apply to a physiological viral infection. |
format | Online Article Text |
id | pubmed-6166132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61661322018-10-04 Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection Tomasello, Elena Naciri, Karima Chelbi, Rabie Bessou, Gilles Fries, Anissa Gressier, Elise Abbas, Abdenour Pollet, Emeline Pierre, Philippe Lawrence, Toby Vu Manh, Thien‐Phong Dalod, Marc EMBO J Articles Plasmacytoid dendritic cells (pDC) are the major source of type I interferons (IFN‐I) during viral infections, in response to triggering of endosomal Toll‐like receptors (TLRs) 7 or 9 by viral single‐stranded RNA or unmethylated CpG DNA, respectively. Synthetic ligands have been used to disentangle the underlying signaling pathways. The adaptor protein AP3 is necessary to transport molecular complexes of TLRs, synthetic CpG DNA, and MyD88 into endosomal compartments allowing interferon regulatory factor 7 (IRF7) recruitment whose phosphorylation then initiates IFN‐I production. High basal expression of IRF7 by pDC and its further enhancement by positive IFN‐I feedback signaling appear to be necessary for robust cytokine production. In contrast, we show here that in vivo during mouse cytomegalovirus (MCMV) infection pDC produce high amounts of IFN‐I downstream of the TLR9‐to‐MyD88‐to‐IRF7 signaling pathway without requiring IFN‐I positive feedback, high IRF7 expression, or AP3‐driven endosomal routing of TLRs. Hence, the current model of the molecular requirements for professional IFN‐I production by pDC, established by using synthetic TLR ligands, does not strictly apply to a physiological viral infection. John Wiley and Sons Inc. 2018-08-21 2018-10-01 /pmc/articles/PMC6166132/ /pubmed/30131424 http://dx.doi.org/10.15252/embj.201798836 Text en © 2018 The Authors. Published under the terms of the CC BY NC ND 4.0 license This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Articles Tomasello, Elena Naciri, Karima Chelbi, Rabie Bessou, Gilles Fries, Anissa Gressier, Elise Abbas, Abdenour Pollet, Emeline Pierre, Philippe Lawrence, Toby Vu Manh, Thien‐Phong Dalod, Marc Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection |
title | Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection |
title_full | Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection |
title_fullStr | Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection |
title_full_unstemmed | Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection |
title_short | Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection |
title_sort | molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166132/ https://www.ncbi.nlm.nih.gov/pubmed/30131424 http://dx.doi.org/10.15252/embj.201798836 |
work_keys_str_mv | AT tomaselloelena moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT nacirikarima moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT chelbirabie moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT bessougilles moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT friesanissa moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT gressierelise moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT abbasabdenour moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT polletemeline moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT pierrephilippe moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT lawrencetoby moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT vumanhthienphong moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection AT dalodmarc moleculardissectionofplasmacytoiddendriticcellactivationinvivoduringaviralinfection |